Venkatesh Rajamanickam

6PUBLICATIONS
16CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2024
IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells.

Olivier Fesneau, Kimberly A Samson, Wesley Rosales

|Apr 06, 2021
Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens.

Venkatesh Rajamanickam, Carmen Ballesteros-Merino, Kimberly Samson

|Feb 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.

Rebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye

|Jan 27, 2021
Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth.

Mark D Badeaux, Annah S Rolig, Giulia Agnello

|Dec 14, 2019
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer.

David B Page, Joanna Pucilowska, Katherine G Sanchez

|Apr 14, 2018
Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15.

Michael J Madsen, Stacey Knight, Carol Sweeney

Pageof 1

Frequent Collaborators

2 joint publications

William L Redmond

2 joint publications

Kimberly Samson

1 joint publications

Stacey Knight

1 joint publications

Annah S Rolig